Groundbreaking study finds activator of magnesium dynamics in the body

October 08, 2020

SAN ANTONIO, Texas, USA - Researchers from The University of Texas Health Science Center at San Antonio (UT Health San Antonio) have solved the 100-year-old mystery of what activates magnesium ions in the cell. The discovery is expected to be a springboard for future development of novel drugs to treat cardiovascular disease, metabolic disorders such as diabetes, and other diseases.

Reporting Thursday (Oct. 8) in Cell, scientists in the Joe R. and Teresa Lozano Long School of Medicine at UT Health San Antonio said the magnesium activator is a metabolite called lactate, which is elevated in the blood during intense exercise and in many diseases, including heart disease, diabetes, sepsis and cancer.

"Lactate is a signal that - like a light switch - turns on magnesium ions," said lead author Madesh Muniswamy, PhD, professor of cardiology in the Long School of Medicine. "On lactate's signal, the ions rush out of cellular storehouses called the endoplasmic reticulum."

The team made a second discovery: A protein called Mrs2 transports the released magnesium ions into cell powerhouses known as mitochondria. These power plants generate ATP, which is the energy currency fueling all the processes in the body.

"We believe this loop is essential for health," said study coauthor W. Brian Reeves, MD, chairman of the Department of Medicine at UT Health San Antonio. "If there is a problem with magnesium routing, impairments ensue, such as the diminished mitochondrial function and poor energy production observed in Type 2 diabetes or severe infections."

IP3, the activator for calcium ions, was discovered in 1984. Since that time, the calcium field has grown in monumental fashion, whereas magnesium continued to be a riddle, said coauthor Karthik Ramachandran, Ph.D., postdoctoral fellow in the Muniswamy laboratory.

Coauthor Travis Madaris, a graduate student on the research team, said, "As a student in the lab, this discovery is exciting because it lays out a pathway for multiple publications while I'm in this lab, and most importantly, it can lead to many future discoveries to improve human health."

Madaris is supported by a predoctoral research training fellowship awarded by the National Institutes of Health.

Summing up the discovery, Dr. Muniswamy said: "Magnesium is essential for life. It's in our blood. It's been implicated in and used as a treatment for a variety of diseases, including migraines, cardiovascular diseases, diabetes and preeclampsia. But to take the next step forward, we needed to understand the dynamics of magnesium in our bodies. With this finding, we believe we have laid out one of the pillars of support that the scientific world needed."
-end-
The National Institutes of Health (National Institute of General Medical Sciences and National Heart, Lung, and Blood Institute); the U.S. Department of Defense; and the San Antonio Partnership for Precision Therapeutics provided funding for this research.

Lactate Elicits ER-Mitochondrial Mg2+ Dynamics to Integrate Cellular Metabolism

Cassidy C. Daw, Karthik Ramachandran, Benjamin T. Enslow, Soumya Maity, Brian Bursic, Matthew J. Novello, Cherubina S. Rubannelsonkumar, Ayah H. Mashal, Joel Ravichandran, Terry M. Bakewell, Weiwei Wang, Kang Li, Travis R. Madaris, Christopher E. Shannon, Luke Norton, Soundarya Kandala, Jeffrey Caplan, Subramanya Srikantan, Peter B. Stathopulos, W. Brian Reeves and Madesh Muniswamy

First published: Oct. 8, 2020, Cell

https://doi.org/10.1016/j.cell.2020.08.049

at The University of Texas Health Science Center at San Antonio is named for Texas philanthropists Joe R. and Teresa Lozano Long. The school is the largest educator of physicians in South Texas, many of whom remain in San Antonio and the region to practice medicine. The school teaches more than 900 students and trains 800 residents each year. As a beacon of multicultural sensitivity, the school annually exceeds the national medical school average of Hispanic students enrolled. The school's clinical practice is the largest multidisciplinary medical group in South Texas with 850 physicians in more than 100 specialties. The school has a highly productive research enterprise where world leaders in Alzheimer's disease, diabetes, cancer, aging, heart disease, kidney disease and many other fields are translating molecular discoveries into new therapies. The Long School of Medicine is home to a National Cancer Institute-designated cancer center known for prolific clinical trials and drug development programs, as well as a world-renowned center for aging and related diseases.

, also referred to as UT Health San Antonio, is one of the country's leading health sciences universities and is designated as a Hispanic-Serving Institution by the U.S. Department of Education. With missions of teaching, research, patient care and community engagement, its schools of medicine, nursing, dentistry, health professions and graduate biomedical sciences have graduated more than 37,000 alumni who are leading change, advancing their fields, and renewing hope for patients and their families throughout South Texas and the world. To learn about the many ways "We make lives better®," visit http://www.uthscsa.edu.

Stay connected with The University of Texas Health Science Center at San Antonio on
Impact.


University of Texas Health Science Center at San Antonio

Related Diabetes Articles from Brightsurf:

New diabetes medication reduced heart event risk in those with diabetes and kidney disease
Sotagliflozin - a type of medication known as an SGLT2 inhibitor primarily prescribed for Type 2 diabetes - reduces the risk of adverse cardiovascular events for patients with diabetes and kidney disease.

Diabetes drug boosts survival in patients with type 2 diabetes and COVID-19 pneumonia
Sitagliptin, a drug to lower blood sugar in type 2 diabetes, also improves survival in diabetic patients hospitalized with COVID-19, suggests a multicenter observational study in Italy.

Making sense of diabetes
Throughout her 38-year nursing career, Laurel Despins has progressed from a bedside nurse to a clinical nurse specialist and has worked in medical, surgical and cardiac intensive care units.

Helping teens with type 1 diabetes improve diabetes control with MyDiaText
Adolescence is a difficult period of development, made more complex for those with Type 1 diabetes mellitus (T1DM).

Diabetes-in-a-dish model uncovers new insights into the cause of type 2 diabetes
Researchers have developed a novel 'disease-in-a-dish' model to study the basic molecular factors that lead to the development of type 2 diabetes, uncovering the potential existence of major signaling defects both inside and outside of the classical insulin signaling cascade, and providing new perspectives on the mechanisms behind insulin resistance in type 2 diabetes and possibly opportunities for the development of novel therapeutics for the disease.

Tele-diabetes to manage new-onset diabetes during COVID-19 pandemic
Two new case studies highlight the use of tele-diabetes to manage new-onset type 1 diabetes in an adult and an infant during the COVID-19 pandemic.

Genetic profile may predict type 2 diabetes risk among women with gestational diabetes
Women who go on to develop type 2 diabetes after having gestational, or pregnancy-related, diabetes are more likely to have particular genetic profiles, suggests an analysis by researchers at the National Institutes of Health and other institutions.

Maternal gestational diabetes linked to diabetes in children
Children and youth of mothers who had gestational diabetes during pregnancy are at increased risk of diabetes themselves, according to new research published in CMAJ (Canadian Medical Association Journal).

Two diabetes medications don't slow progression of type 2 diabetes in youth
In youth with impaired glucose tolerance or recent-onset type 2 diabetes, neither initial treatment with long-acting insulin followed by the drug metformin, nor metformin alone preserved the body's ability to make insulin, according to results published online June 25 in Diabetes Care.

People with diabetes visit the dentist less frequently despite link between diabetes, oral health
Adults with diabetes are less likely to visit the dentist than people with prediabetes or without diabetes, finds a new study led by researchers at NYU Rory Meyers College of Nursing and East Carolina University's Brody School of Medicine.

Read More: Diabetes News and Diabetes Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.